[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Ministerio de Salud de la Rep[uacute]blica de Panam[aacute] (MINSA)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $10,000,000 for Year 1 of funding to the
Ministerio de Salud de la Rep[uacute]blica de Panam[aacute]
{MINSA{time} . The award will contribute to the achievement of 95-95-95
targets (95% of HIV-positive individuals knowing their status, 95% of
those receiving ART [Antiretroviral therapy], and 95% of those
achieving viral suppression) in Panama by introducing or scaling up
high-impact HIV prevention, testing, linkage, and treatment models
across the continuum of care and strengthening HIV laboratory and
information systems. Funding amounts for years 2-5 will be set at
continuation.
DATES: The period for this award will be September 30, 2022 through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Lily de Leon, Center for Global
Health, Centers for Disease Control and Prevention, 18 Avenida 11-37,
Zona 15, VHIII, Telephone: 800-232-6348, Email: [email protected].
SUPPLEMENTARY INFORMATION: The single-source award will include key HIV
prevention and diagnosis activities: Index testing, differentiated
service modalities at key population testing facilities, self-testing,
Pre-Exposure Prophylaxis (PreP), rapid recency testing and response to
clusters of recent transmission, and linkage to treatment for newly
diagnosed individuals in Panama. Additionally, key HIV treatment
activities will include linkage to care registries, early treatment
initiation, differentiated service delivery models, opportunistic
infection diagnosis and treatment, lost-to follow-up reengagement,
quality assurance in Viral Load (VL) networks, and drug resistance
monitoring.
MINSA is in a unique position to conduct this work, as it is the
sole organization authorized to oversee the regions and medical
sanitary areas covered by health institutions deemed to be scattered
and decentralized in Panama. Since its creation in 1969, MINSA has
served to streamline programs within these areas by setting up
satellite systems in which higher ranking institutions are responsible
for coordinating collaboration between medical-sanitary area officials,
urban doctors, and the general hospital staff of these complex
institutions.
Summary of the Award
Recipient: Ministerio de Salud de la Rep[uacute]blica de
Panam[aacute] (MINSA).
Purpose of the Award: The purpose of this award is to contribute to
the achievement of 95-95-95 targets in Panama by introducing or scaling
up high-impact HIV prevention, testing, linkage, and treatment models
across the continuum of care and strengthening HIV laboratory and
information systems.
Amount of Award: The approximate year 1 funding amount will be
$10,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the
availability of funds. Fund amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Period of Performance: September 30, 2022 through September 29,
2027.
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-02406 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P